These effects, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,two guidance the idea of focusing on ACKR3 as a novel approach to modulate the opioid method, which could open new therapeutic avenues for opioid-relevant disord